1163-121 Prognostic role of neutrophil and lymphocyte counts in heart failure: Results from Val-HeFT

Inder S. Anand; Joseph Yen; Viorel G. Florea; Allen Hester; Robert Glazer; Roberto Latini; Aldo Maggioni; Jay N. Cohn

doi:10.1016/s0735-1097(04)90974-6

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2004

1163-114 Prognostic role of plasma C-reactive protein in heart failure: Results from Val-HeFT

Inder S. Anand, Roberto Latini, Serge Masson, Dianne Judd, YannTong Chiang, Robert Glazer, E. W. T. Morris, Aldo Maggioni, Gianni Tognoni, Stefano Signorini, Jay N. Cohn

Article2003

Prognostic Value of Aldosterone in Heart Failure – Results from Val-HeFT

Inder S. Anand, Roberto Latini, Robert Glazer, Allen Hester, Serge Masson, Aldo Maggioni, Nora Aknay, Jay N. Cohn

Article2007

Clinical, Neurohormonal, and Inflammatory Markers and Overall Prognostic Role of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure: Data From the Val-HeFT Heart Failure Trial

Lidia Staszewsky, Maylene Wong, Serge Masson, Simona Barlera, Elisa Carretta, Aldo Maggioni, Inder S. Anand, Jay N. Cohn, Gianni Tognoni, Roberto Latini

Article2005

Valsartan Reduces the Incidence of Atrial Fibrillation in Patients With Heart Failure: Results From the Valsartan Heart Failure Trial (Val-HeFT)

Aldo Maggioni, Roberto Latini, Peter E. Carson

Article2005

Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: Results from the Valsartan Heart Failure Trial (Val-HeFT)

Aldo Maggioni, Roberto Latini, Peter E. Carson, Steven Singh, Simona Barlera, Robert Glazer, Serge Masson, E Cerè, Gianni Tognoni, Jay N. Cohn